ARS Pharmaceuticals Inc holding history
As of Nov. 6, 2026 (UTC)
| Dec. 31, 2025 | 559,959 | $6,523,522 | 0.37% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 13, 2026 |
| March 31, 2026 | 727,154 | $5,839,047 | 0.38% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 1, 2026 |
| June 30, 2026 | 1,133,046 | $9,075,698 | 0.54% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | July 31, 2026 |
| Sept. 30, 2026 | 908,428 | $3,915,325 | 0.23% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 2, 2026 |
4 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.